Insider Trading May 29, 2026 08:47 PM

Paysign Executive Sells Shares Following Strong Q1 Performance and Analyst Upgrades

Director Joan Herman divests stock through a pre-planned trading schedule amidst company revenue growth and improved earnings.

By Nina Shah PAYS

Joan M. Herman, an executive and director at Paysign, Inc., sold a block of shares on May 26, 2026. This transaction occurred against a backdrop of the company's robust first-quarter results for 2026, which notably exceeded expectations across both revenue and earnings metrics. Furthermore, industry analysts have maintained positive ratings, citing strong financial health.

Paysign Executive Sells Shares Following Strong Q1 Performance and Analyst Upgrades
PAYS

Key Points

  • The company reported significantly stronger than expected first-quarter results for 2026, with EPS reaching $0.09 (80% above forecast) and revenue hitting $28.04 million (51% year-over-year growth).
  • Analyst confidence remains high, evidenced by DA Davidson maintaining a Buy rating and setting a price target of $9.00 for Paysign.
  • Executive director Joan M. Herman sold shares through a pre-arranged Rule 10b5-1 trading plan, while her direct holdings remain substantial at 813,989 shares.

Joan M. Herman, who serves as Executive Vice President of Operations and holds a director position at Paysign, Inc. (NASDAQ:PAYS), completed the sale of 22,534 shares of the company's common stock on May 26, 2026. The total value realized from this disposition amounted to $158,037. During the transaction, the shares were bought at prices that ranged between $7.0001 and $7.0249 per share.

It is important to note that the sale was executed under the terms of a Rule 10b5-1 trading plan, a mechanism adopted by Ms. Herman on September 12, 2025. Following this specific transaction, Joan M. Herman's direct holdings in Paysign common stock total 813,989 shares.

Market Context and Company Performance

The timing of the share sale occurs amid several positive developments for Paysign. The company recently reported its first-quarter results for 2026, figures that substantially surpassed both analyst earnings expectations and revenue forecasts. For the quarter, Paysign achieved an earnings per share (EPS) of $0.09. This figure represents a significant overperformance compared to the projected $0.05, translating to an 80% increase relative to initial estimates.

Revenue figures for the period reached $28.04 million, exceeding the anticipated revenue benchmark of $27 million. This achievement signifies robust financial growth, representing a total year-over-year revenue increase of 51%. Complementing these metrics, the adjusted EBITDA also saw substantial gains, rising by 113% when compared to the same quarter in the prior year.

Analyst Outlook and Valuation

The positive operational data has been reflected in analyst sentiment. DA Davidson reaffirmed its Buy rating on Paysign, attaching a price target of $9.00, which underscores confidence in the company's continued financial trajectory. Separately, an analysis provided by InvestingPro suggests that the stock may currently be undervalued at existing market levels. Investors seeking deeper due diligence have access to a comprehensive Pro Research Report detailing PAYS, among over 1,400 available reports on the platform.

In summary, while executive activity involving the sale of shares is noted, these transactions are structured through pre-approved trading plans. The underlying corporate performance, characterized by strong Q1 results and positive analyst coverage, suggests a favorable outlook for Paysign's financial standing.

Risks

  • The article does not explicitly detail any immediate operational or financial risks facing the company.
  • Reliance on pre-planned selling (Rule 10b5-1) for executive transactions suggests that current share sales are non-discretionary, but it does not negate general market volatility risk.
  • While analyst ratings are positive, future performance hinges on sustaining the high growth rates seen in Q1 2026 across both revenue and EBITDA.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026